Cited 27 times in
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.